FORMULASI KOMBINASI RIFAMPISIN DAN ARTINM DALAM SISTEM NANOPARTIKEL KITOSAN UNTUK TUJUAN PENGGUNAAN ORAL

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis which can damage many organs, mainly affect the lungs. Rifampicin as the first line of antituberculosis drug has several problems related to its stability, solubility, and bioavailability towards the presence of other...

Full description

Saved in:
Bibliographic Details
Main Author: Dewi Intani, Rizka
Format: Final Project
Language:Indonesia
Online Access:https://digilib.itb.ac.id/gdl/view/44578
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Institut Teknologi Bandung
Language: Indonesia
id id-itb.:44578
spelling id-itb.:445782019-10-28T15:34:18ZFORMULASI KOMBINASI RIFAMPISIN DAN ARTINM DALAM SISTEM NANOPARTIKEL KITOSAN UNTUK TUJUAN PENGGUNAAN ORAL Dewi Intani, Rizka Indonesia Final Project tuberculosis, nanoparticles, chitosan, rifampicin, artin-M INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/44578 Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis which can damage many organs, mainly affect the lungs. Rifampicin as the first line of antituberculosis drug has several problems related to its stability, solubility, and bioavailability towards the presence of other antituberculosis drug. Artin-M is a lectin from jackfruit (Artocarpus integrifolia) seeds which has immunostimulant activities by inducing immune cells with glycosylated receptor on the surface such as macrophages and dendritic cells to produce cytokines. This study aims to formulate rifampicin along with artin-M into nanoparticles for oral route of administration by using low molecular weight chitosan and glucomannan with target of particle size less than 600 nm. Nanoparticles were prepared by ionic gelation using sodium tripolyphosphate as crosslinking agent (STPP). The formula was optimized to provide the highest entrapment efficiency of artin-M and rifampicin with appropriate particle size. Artin-M was adsorbed to glucomannan solution in order to bind specifically, and subsequently incorporated into nanoparticles. Evaluation of nanoparticles consisted of particle size, polidispersity index, zeta potential, entrapment efficiency of rifampicin, hemagglutination test and SDS PAGE of Artin-M. The optimum formula was obtained from 20 mg/mL chitosan at pH 4 with the additions of 6 mg/mL STPP, 10 mg/mL glucomannan, 20% (w/v) polysorbate 80, 1.9 mg/mL artin-M to glucomannan ratio, 0.75% (w/v) of rifampicin, and at ratio of chitosan : STPP : glucomannan was 5 : 2 : 1. Nanopaticles were obtained in average particle size of 405.2 ± 7.02 nm, polydispersity index of 0.218 ± 0.006, zeta potential of +31.65 mV, rifampicin entrapment efficiency of 53.26 ± 0.34%, and hemagglutination test indicated that 100% of artin-M was entrapped within nanoparticles. text
institution Institut Teknologi Bandung
building Institut Teknologi Bandung Library
continent Asia
country Indonesia
Indonesia
content_provider Institut Teknologi Bandung
collection Digital ITB
language Indonesia
description Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis which can damage many organs, mainly affect the lungs. Rifampicin as the first line of antituberculosis drug has several problems related to its stability, solubility, and bioavailability towards the presence of other antituberculosis drug. Artin-M is a lectin from jackfruit (Artocarpus integrifolia) seeds which has immunostimulant activities by inducing immune cells with glycosylated receptor on the surface such as macrophages and dendritic cells to produce cytokines. This study aims to formulate rifampicin along with artin-M into nanoparticles for oral route of administration by using low molecular weight chitosan and glucomannan with target of particle size less than 600 nm. Nanoparticles were prepared by ionic gelation using sodium tripolyphosphate as crosslinking agent (STPP). The formula was optimized to provide the highest entrapment efficiency of artin-M and rifampicin with appropriate particle size. Artin-M was adsorbed to glucomannan solution in order to bind specifically, and subsequently incorporated into nanoparticles. Evaluation of nanoparticles consisted of particle size, polidispersity index, zeta potential, entrapment efficiency of rifampicin, hemagglutination test and SDS PAGE of Artin-M. The optimum formula was obtained from 20 mg/mL chitosan at pH 4 with the additions of 6 mg/mL STPP, 10 mg/mL glucomannan, 20% (w/v) polysorbate 80, 1.9 mg/mL artin-M to glucomannan ratio, 0.75% (w/v) of rifampicin, and at ratio of chitosan : STPP : glucomannan was 5 : 2 : 1. Nanopaticles were obtained in average particle size of 405.2 ± 7.02 nm, polydispersity index of 0.218 ± 0.006, zeta potential of +31.65 mV, rifampicin entrapment efficiency of 53.26 ± 0.34%, and hemagglutination test indicated that 100% of artin-M was entrapped within nanoparticles.
format Final Project
author Dewi Intani, Rizka
spellingShingle Dewi Intani, Rizka
FORMULASI KOMBINASI RIFAMPISIN DAN ARTINM DALAM SISTEM NANOPARTIKEL KITOSAN UNTUK TUJUAN PENGGUNAAN ORAL
author_facet Dewi Intani, Rizka
author_sort Dewi Intani, Rizka
title FORMULASI KOMBINASI RIFAMPISIN DAN ARTINM DALAM SISTEM NANOPARTIKEL KITOSAN UNTUK TUJUAN PENGGUNAAN ORAL
title_short FORMULASI KOMBINASI RIFAMPISIN DAN ARTINM DALAM SISTEM NANOPARTIKEL KITOSAN UNTUK TUJUAN PENGGUNAAN ORAL
title_full FORMULASI KOMBINASI RIFAMPISIN DAN ARTINM DALAM SISTEM NANOPARTIKEL KITOSAN UNTUK TUJUAN PENGGUNAAN ORAL
title_fullStr FORMULASI KOMBINASI RIFAMPISIN DAN ARTINM DALAM SISTEM NANOPARTIKEL KITOSAN UNTUK TUJUAN PENGGUNAAN ORAL
title_full_unstemmed FORMULASI KOMBINASI RIFAMPISIN DAN ARTINM DALAM SISTEM NANOPARTIKEL KITOSAN UNTUK TUJUAN PENGGUNAAN ORAL
title_sort formulasi kombinasi rifampisin dan artinm dalam sistem nanopartikel kitosan untuk tujuan penggunaan oral
url https://digilib.itb.ac.id/gdl/view/44578
_version_ 1821999182624325632